Wiegant Fred, Van Wijk Roeland
Faculty of Science, Department of Biology, Molecular Cell Biology/Cellular Dynamics, Utrecht University, P.O. Box 80056, 3508 TB Utrecht, The Netherlands.
Homeopathy. 2010 Jan;99(1):3-14. doi: 10.1016/j.homp.2009.10.002.
This paper describes the results of a research program focused on the beneficial effect of low dose stress conditions that were applied according to the similia principle to cells previously disturbed by more severe stress conditions. In first instance, we discuss criteria for research on the similia principle at the cellular level. Then, the homologous ('isopathic') approach is reviewed, in which the initial (high dose) stress used to disturb cellular physiology and the subsequent (low dose) stress are identical. Beneficial effects of low dose stress are described in terms of increased cellular survival capacity and at the molecular level as an increase in the synthesis of heat shock proteins (hsps). Both phenomena reflect a stimulation of the endogenous cellular self-recovery capacity. Low dose stress conditions applied in a homologous approach stimulate the synthesis of hsps and enhance survival in comparison with stressed cells that were incubated in the absence of low dose stress conditions. Thirdly, the specificity of the low dose stress condition is described where the initial (high dose) stress is different in nature from the subsequently applied (low dose) stress; the heterologous or 'heteropathic' approach. The results support the similia principle at the cellular level and add to understanding of how low dose stress conditions influence the regulatory processes underlying self-recovery. In addition, the phenomenon of 'symptom aggravation' which is also observed at the cellular level, is discussed in the context of self-recovery. Finally, the difference in efficiency between the homologous and the heterologous approach is discussed; a perspective is indicated for further research; and the relationship between studies on the similia principle and the recently introduced concept of 'postconditioning hormesis' is emphasized.
本文描述了一项研究计划的结果,该计划聚焦于低剂量应激条件的有益作用,这些低剂量应激条件是根据顺势疗法原则应用于先前受到更严重应激条件干扰的细胞的。首先,我们讨论细胞水平上顺势疗法原则的研究标准。然后,回顾同源(“同病疗法”)方法,其中用于干扰细胞生理的初始(高剂量)应激与随后的(低剂量)应激是相同的。低剂量应激的有益作用表现为细胞存活能力增强,在分子水平上则表现为热休克蛋白(hsps)合成增加。这两种现象都反映了内源性细胞自我恢复能力的增强。与在无低剂量应激条件下培养的应激细胞相比,以同源方法施加的低剂量应激条件刺激了hsps的合成并提高了存活率。第三,描述了低剂量应激条件的特异性,即初始(高剂量)应激与随后施加的(低剂量)应激在性质上不同;即异源或“异病疗法”方法。这些结果支持了细胞水平上的顺势疗法原则,并有助于理解低剂量应激条件如何影响自我恢复的调节过程。此外,还在自我恢复的背景下讨论了在细胞水平上也观察到的“症状加重”现象。最后,讨论了同源方法和异源方法在效率上的差异;指出了进一步研究的方向;并强调了顺势疗法原则研究与最近引入的“后适应应激效应”概念之间的关系。